Strep Throat Treatment Market - Top Companies and Manufacturers

In the News

• Pfizer Inc., declared that the European Commission (EC) has provided marketing authorization for the organization’s 20-valent pneumococcal conjugate vaccine, commercialized in the European Union under the brand name PREVENAR 20®, for active vaccination for the avoidance of intrusive disease, pneumonia, and severe otitis media caused by Streptococcus pneumoniae in kids, children, and adolescents from 6 weeks to lower than 18 years of age.
• Pfizer Inc. announced top-line ABRYSVO® vaccine efficiency and protection information for a respiratory syncytial virus (RSV) in adults 60 years of age and older following a second season in the Northern and Southern Hemispheres from the continuous pivotal Phase 3 clinical trial RENOIR (RSV vaccine Efficiency study iNOlder adults Immunized against RSV disease).